In a percentage of patients with hepatic fields of cancerization, an overregulation of TGFβ signaling, T-cell depletion and overexpression of immune checkpoints have been demonstrated, which was associated with an increased risk of hepatocellular carcinoma (24). This evidence concerns the gene TGFB1 and hepatocellular carcinoma.